Royce & Associates LP Profound Medical Corp. Transaction History

Royce & Associates LP

$9.25 Billion
Q2 2025

A detailed history of Royce & Associates LP transactions in Profound Medical Corp. stock. As of the latest transaction made, Royce & Associates LP holds 764,906 shares of PROF stock, worth $4.25 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

764,906

Previous 761,799 0.41%

Holding current value

$4.25 Million

Previous $4.43 Million 1.78%

% of portfolio

0.05%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$4.04 - $6.86 $12,552 - $21,314	3,107 Added 0.41%	764,906 $4.51 Million
Q1 2025 May 06, 2025	SELL	$5.81 - $7.9 $17,430 - $23,700	-3,000 Reduced 0.39%	761,799 $4.43 Million
Q4 2024 Feb 10, 2025	BUY	$6.98 - $8.96 $1.36 Million - $1.75 Million	195,501 Added 34.34%	764,799 $5.74 Million
Q3 2024 Nov 06, 2024	BUY	$7.47 - $11.18 $26,145 - $39,130	3,500 Added 0.62%	569,298 $4.53 Million
Q2 2024 Aug 13, 2024	BUY	$7.25 - $9.07 $10,875 - $13,605	1,500 Added 0.27%	565,798 $4.75 Million
Q4 2023 Feb 12, 2024	SELL	$7.85 - $11.18 $43,960 - $62,608	-5,600 Reduced 0.98%	564,298 $4.79 Million
Q3 2023 Nov 09, 2023	BUY	$7.91 - $13.27 $30,849 - $51,753	3,900 Added 0.69%	569,898 $5.81 Million
Q2 2023 Aug 07, 2023	SELL	$9.27 - $14.88 $47,277 - $75,888	-5,100 Reduced 0.89%	565,998 $7.36 Million
Q1 2023 May 04, 2023	BUY	$8.85 - $13.27 $202,665 - $303,883	22,900 Added 4.18%	571,098 $5.3 Million
Q4 2022 May 23, 2023	SELL	$3.18 - $10.91 $72,822 - $249,839	-22,900 Reduced 4.01%	548,198 $5.97 Million
Q4 2022 Feb 13, 2023	BUY	$3.18 - $10.91 $328,494 - $1.13 Million	103,300 Added 23.22%	548,198 $5.86 Million
Q3 2022 Nov 03, 2022	SELL	$3.99 - $9.3 $231,420 - $539,400	-58,000 Reduced 11.53%	444,898 $1.8 Million
Q2 2022 Aug 04, 2022	SELL	$6.34 - $9.53 $13,314 - $20,013	-2,100 Reduced 0.42%	502,898 $3.67 Million
Q1 2022 May 05, 2022	SELL	$8.16 - $11.33 $501,840 - $696,795	-61,500 Reduced 10.86%	504,998 $4.54 Million
Q4 2021 Feb 07, 2022	BUY	$10.38 - $15.2 $507,561 - $743,249	48,898 Added 9.45%	566,498 $6.39 Million
Q3 2021 Nov 10, 2021	BUY	$13.6 - $17.88 $557,600 - $733,080	41,000 Added 8.6%	517,600 $7.56 Million
Q2 2021 Aug 06, 2021	BUY	$16.0 - $20.59 $291,200 - $374,738	18,200 Added 3.97%	476,600 $7.76 Million
Q1 2021 May 10, 2021	BUY	$19.16 - $28.09 $3.02 Million - $4.42 Million	157,400 Added 52.29%	458,400 $9.19 Million
Q4 2020 Feb 08, 2021	BUY	$16.4 - $22.9 $4.77 Million - $6.66 Million	291,000 Added 2910.0%	301,000 $6.19 Million
Q3 2020 Nov 12, 2020	SELL	$14.05 - $18.13 $3.98 Million - $5.13 Million	-283,000 Reduced 96.59%	10,000 $176,000
Q1 2020 May 12, 2020	BUY	$6.88 - $19.7 $674,240 - $1.93 Million	98,000 Added 50.26%	293,000 $2.82 Million
Q4 2019 Feb 06, 2020	BUY	$6.4 - $11.95 $1.25 Million - $2.33 Million	195,000 New	195,000 $2.22 Million

Others Institutions Holding PROF

# of Institutions

Shares Held

12.7M

Call Options Held

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $116M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Profound Medical Corp. Transaction History